Skip to content
Languages
Accessibility
SiteMap
Help
Find us on
Facebook,
Twitter,
YouTube
Search
Home
Parliamentary Business
Business Bulletin
Official Report
Committees
Bills
The Chamber
Motions, Questions and Answers
Research Briefings and Fact Sheets
Parliamentary Procedure
Public and Privilege Holidays
MSPs
Current MSPs
Previous MSPs
Register of Interests
Cross-Party Groups
Members' Expenses Scheme
MSP Salaries and Pensions
Election Results
Find Your MSPs
Code of Conduct for MSPs
Ministers & Law Officers
Visit & Learn
Visiting The Parliament
Events and Exhibitions
Education
Gaelic service
History
Information resources
Environment and Sustainability
How the Parliament Works
Explore Parliament
Getting Involved
Petitions
Parliament on social media
Guide for Committee Witnesses
Witness diversity - guide for external organisations
Organising a protest
Lobbying
Your Voice
Young Women Lead
20 years of the Scottish Parliament
Community Outreach
News & Parliament TV
News
Parliament TV
Media Resources
About the Parliament
Corporate Governance
The Parliamentary Service
The Presiding Officer
The Parliament at home and abroad
Data Protection
Written responses on Access to newly licensed medicines
ANM001 Pfizer UK (171KB pdf)
ANM002 The Royal College of Physicians (92KB pdf)
ANM003 aHUSUK (100KB pdf)
ANM004 Novartis Pharmaceuticals (121KB pdf)
ANM005 Cancer Research UK (110KB pdf)
ANM006 Myeloma UK (94KB pdf)
ANM007 James Whale Fund for Kidney cancer (158KB pdf)
ANM008 Macmillan Cancer Support (145KB pdf)
ANM009 David Cameron Professor Jeff Evans and Dr Marianne Nicolson (197KB pdf)
ANM010 Merck Serono Ltd (69KB pdf)
ANM011 Roche Products Ltd (375KB pdf)
ANM012 Patient and Public Involvement Group (PAPIG) of the Scottish Medicines Consortium (SMC) (96KB pdf)
ANM013 Bristol Myers Squibb (386KB pdf)
ANM014 Prostate Cancer UK ((97KB pdf)
ANM015 Melanoma Action Support Scotland (242KB pdf)
ANM016 Rare Disease UK (RDUK) (136KB pdf)
ANM017 Scottish Melanoma Group the Scottish Dermatology Skin Cancer Group and affiliated clinicians (167KB pdf)
ANM018 Professor Charlie Gourley (150KB pdf)
ANM019 ABPI Scotland (543KB pdf)
ANM020 PNH Alliance and PNH Scotland (180KB pdf)
ANM021 On behalf of Oncologists specialising in the treatment of colectoral cancel within Scotland (82KB pdf)
ANM022 Scottish Government (329KB pdf)
ANM023 Scottish Medicines Consortium (261KB pdf)
ANM024 Shire (210KB pdf)
Responses from 14 area NHS Boards to Committee's Individual Patient Treatment Requests questionnaire (163KB pdf)
Supplementary Submission
ABPI Scotland 20 September 2012 (107KB pdf)
Pfizer UK (97kb pdf)
ABPI Scotland 26 November 2012 (336KB pdf)
Alliance Scotland 21 February 2013 (88KB pdf)
Late Submissions
Carrie Featherstone, Chair of Beatson West of Scotland Consultants Committee, Beatson West of Scotland Cancer Centre (12KB pdf)
Caroline McManus individual (71KB pdf)
Anonymous Submission (115KB pdf)
Personal statement by Paul Sharp (177KB pdf)
Andy Carver, Prevention and Care Adviser, British Heart Foundation Scotland (153KB pdf)
Association for Glycogen Storage Disease (129KB pdf)
Karen Facey individual (240KB pdf)
Beating Bowel Cancer (231KB pdf)
Beating Bowel Cancer - A Triple lock clinical option (139KB pdf)
Related Links
Access to newly licensed medicines
x
This website is using cookies.
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website.
Okay
Tell me more